<DOC>
	<DOC>NCT02831868</DOC>
	<brief_summary>To determine the safety, tolerability and efficacy of the HAVAI device as a minimally invasive double anchor and suture orthopedic implant fixation device for IMA reduction in cases of HV deformities when the IMA is greater than 120 and less than or equal 200.</brief_summary>
	<brief_title>Safety, Tolerability and Efficacy of HAVAI, a Minimal Invasive Double Anchor and Suture Orthopedic Implant Fixation Device Implant and Assistive Tools for Correction of Inter-metatarsal Angle</brief_title>
	<detailed_description />
	<mesh_term>Hallux Valgus</mesh_term>
	<criteria>1. Adult males and female subjects, aged 20 to 75 years old, inclusive, at screening visit. 2. Subject weighing &lt;100 kg and body mass index (BMI) &lt;32 kg/m2. 3. Subjects with confirmed diagnosis of HV deformity based on radiography assessment of IMA &gt; 12ยบ and less than or equal to 20. 4. Subjects who need distal osteotomy of the MT1 as part of their surgery. 5. Able and willing to comply with the requirements of the protocol. 6. Able to understand and sign written informed consent to participate in the study. 1. Contraindication to implantation procedure 2. History of: Diabetes mellitus Claudication, known peripheral vascular disease or no palpable pulses (DP or TP). Known rheumatoid disease. Previously diagnosed gout or any systemic inflammatory arthropathy. Xray evidence of osteoarthritis of MTPJ1. Previous neorological conditions associated with spasticity. Prior operation on MT1 or MT2. Fracture (past or present) of MT1 or MT2. 3. Known osteoarthritis. 4. Aseptic necrosis or any deformity of MT2 head. 5. Pregnant women or women with childbearing potential who are not obliged to take any contraception measures 6. Subject is currently enrolled in or has not yet completed at least 30 days since ending other investigational device or drug study(s), or subject is receiving other investigational agent(s) 7. Any condition that may jeopardize study participation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>